Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Language Development | 8 | 2024 | 24 | 4.430 |
Why?
|
| Parent-Child Relations | 5 | 2024 | 83 | 2.580 |
Why?
|
| Parents | 9 | 2024 | 307 | 2.420 |
Why?
|
| Child Development | 4 | 2021 | 174 | 2.410 |
Why?
|
| Infant | 19 | 2024 | 3363 | 1.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2024 | 569 | 0.970 |
Why?
|
| House Calls | 2 | 2021 | 13 | 0.880 |
Why?
|
| Child, Preschool | 18 | 2024 | 3974 | 0.790 |
Why?
|
| Education, Nonprofessional | 2 | 2020 | 4 | 0.770 |
Why?
|
| Parenting | 2 | 2020 | 79 | 0.740 |
Why?
|
| Postnatal Care | 1 | 2021 | 31 | 0.710 |
Why?
|
| Culture | 1 | 2021 | 54 | 0.700 |
Why?
|
| Schools | 1 | 2021 | 84 | 0.680 |
Why?
|
| Educational Status | 2 | 2021 | 202 | 0.680 |
Why?
|
| Physical Examination | 1 | 2021 | 154 | 0.670 |
Why?
|
| Speech | 1 | 2021 | 91 | 0.660 |
Why?
|
| Child Language | 2 | 2024 | 6 | 0.640 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 7 | 0.610 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 19 | 0.610 |
Why?
|
| Child Health Services | 1 | 2019 | 51 | 0.590 |
Why?
|
| Poverty | 2 | 2024 | 196 | 0.560 |
Why?
|
| Infant, Newborn | 7 | 2021 | 2614 | 0.550 |
Why?
|
| Communication Barriers | 1 | 2017 | 32 | 0.540 |
Why?
|
| Social Environment | 2 | 2016 | 195 | 0.530 |
Why?
|
| Economics, Behavioral | 1 | 2017 | 7 | 0.520 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 111 | 0.520 |
Why?
|
| Fundoplication | 3 | 2009 | 73 | 0.510 |
Why?
|
| Pediatrics | 1 | 2021 | 399 | 0.510 |
Why?
|
| Single-Blind Method | 4 | 2021 | 162 | 0.500 |
Why?
|
| Mothers | 1 | 2017 | 155 | 0.490 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 635 | 0.490 |
Why?
|
| Trachea | 2 | 2008 | 293 | 0.480 |
Why?
|
| Medication Adherence | 1 | 2017 | 122 | 0.470 |
Why?
|
| Social Class | 3 | 2021 | 145 | 0.430 |
Why?
|
| Cochlear Implantation | 2 | 2016 | 34 | 0.420 |
Why?
|
| Child | 14 | 2021 | 7626 | 0.420 |
Why?
|
| Caregivers | 1 | 2016 | 185 | 0.420 |
Why?
|
| Motivation | 1 | 2017 | 310 | 0.420 |
Why?
|
| Humans | 37 | 2024 | 96127 | 0.380 |
Why?
|
| Gastroesophageal Reflux | 2 | 2006 | 121 | 0.370 |
Why?
|
| Female | 25 | 2024 | 50063 | 0.330 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2013 | 220 | 0.330 |
Why?
|
| Deafness | 1 | 2009 | 48 | 0.310 |
Why?
|
| Laryngoscopy | 2 | 2008 | 50 | 0.310 |
Why?
|
| Socioeconomic Factors | 3 | 2019 | 639 | 0.300 |
Why?
|
| Adult | 11 | 2024 | 28718 | 0.300 |
Why?
|
| Esophagus | 1 | 2009 | 111 | 0.280 |
Why?
|
| Tracheal Stenosis | 1 | 2008 | 27 | 0.280 |
Why?
|
| Foreign Bodies | 1 | 2009 | 66 | 0.280 |
Why?
|
| Bronchoscopy | 2 | 2008 | 176 | 0.280 |
Why?
|
| Male | 21 | 2024 | 45870 | 0.270 |
Why?
|
| Pulmonary Veins | 1 | 2008 | 96 | 0.260 |
Why?
|
| Airway Obstruction | 2 | 2006 | 117 | 0.260 |
Why?
|
| Deglutition | 1 | 2006 | 85 | 0.240 |
Why?
|
| Polysomnography | 2 | 2013 | 155 | 0.240 |
Why?
|
| Language | 2 | 2018 | 162 | 0.240 |
Why?
|
| Twins, Conjoined | 1 | 2005 | 4 | 0.230 |
Why?
|
| Chicago | 2 | 2021 | 1503 | 0.230 |
Why?
|
| Bronchi | 1 | 2006 | 234 | 0.220 |
Why?
|
| Diseases in Twins | 1 | 2005 | 65 | 0.220 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2860 | 0.210 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 490 | 0.210 |
Why?
|
| Peritonsillar Abscess | 2 | 2001 | 4 | 0.200 |
Why?
|
| Cesarean Section | 1 | 2005 | 157 | 0.200 |
Why?
|
| Intubation, Intratracheal | 1 | 2005 | 161 | 0.200 |
Why?
|
| Conscious Sedation | 2 | 2001 | 78 | 0.190 |
Why?
|
| Curriculum | 2 | 2019 | 615 | 0.190 |
Why?
|
| Young Adult | 3 | 2020 | 7025 | 0.190 |
Why?
|
| Sialorrhea | 1 | 2002 | 1 | 0.180 |
Why?
|
| Patient Compliance | 2 | 2017 | 239 | 0.180 |
Why?
|
| Submandibular Gland | 1 | 2002 | 18 | 0.180 |
Why?
|
| Parotid Gland | 1 | 2002 | 26 | 0.180 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2001 | 9 | 0.180 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2002 | 53 | 0.170 |
Why?
|
| Cerebral Palsy | 1 | 2002 | 96 | 0.170 |
Why?
|
| Hearing | 1 | 2021 | 64 | 0.170 |
Why?
|
| Communication | 1 | 2024 | 477 | 0.170 |
Why?
|
| Parotid Diseases | 1 | 2000 | 5 | 0.160 |
Why?
|
| Sclerotherapy | 1 | 2000 | 16 | 0.160 |
Why?
|
| Counseling | 1 | 2022 | 174 | 0.160 |
Why?
|
| Quality Assurance, Health Care | 1 | 2021 | 231 | 0.160 |
Why?
|
| Doxycycline | 1 | 2000 | 37 | 0.160 |
Why?
|
| Ear, External | 1 | 1999 | 25 | 0.150 |
Why?
|
| Cysts | 1 | 2000 | 104 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 32 | 0.150 |
Why?
|
| Forecasting | 1 | 2020 | 317 | 0.150 |
Why?
|
| Singing | 1 | 2018 | 7 | 0.140 |
Why?
|
| Reading | 1 | 2018 | 33 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2021 | 938 | 0.140 |
Why?
|
| Pregnancy | 2 | 2021 | 3240 | 0.140 |
Why?
|
| Hearing Tests | 1 | 2017 | 11 | 0.140 |
Why?
|
| Lymphadenitis | 1 | 1997 | 7 | 0.130 |
Why?
|
| Illinois | 1 | 2019 | 531 | 0.130 |
Why?
|
| Palate, Soft | 1 | 1997 | 5 | 0.130 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 1997 | 29 | 0.130 |
Why?
|
| Cognition | 1 | 2022 | 635 | 0.130 |
Why?
|
| Carotid Artery, Internal | 1 | 1997 | 70 | 0.130 |
Why?
|
| Neonatal Screening | 1 | 2017 | 67 | 0.130 |
Why?
|
| Aneurysm, False | 1 | 1997 | 55 | 0.130 |
Why?
|
| Wounds, Penetrating | 1 | 1997 | 56 | 0.130 |
Why?
|
| Smartphone | 1 | 2017 | 54 | 0.120 |
Why?
|
| Adenoidectomy | 2 | 2013 | 23 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 438 | 0.120 |
Why?
|
| Video Recording | 1 | 2017 | 214 | 0.120 |
Why?
|
| Tongue Diseases | 1 | 1996 | 9 | 0.120 |
Why?
|
| Condylomata Acuminata | 1 | 1996 | 15 | 0.120 |
Why?
|
| Tonsillectomy | 2 | 2013 | 31 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1175 | 0.120 |
Why?
|
| Cochlear Implants | 1 | 2016 | 37 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2781 | 0.120 |
Why?
|
| Tongue | 1 | 1996 | 58 | 0.120 |
Why?
|
| Age Factors | 2 | 2017 | 1963 | 0.120 |
Why?
|
| Hearing Loss | 1 | 2016 | 65 | 0.110 |
Why?
|
| Adolescent | 7 | 2017 | 9896 | 0.110 |
Why?
|
| Deglutition Disorders | 2 | 2006 | 126 | 0.110 |
Why?
|
| Reward | 1 | 2017 | 209 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1096 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 847 | 0.110 |
Why?
|
| Education, Continuing | 1 | 2013 | 11 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 1997 | 565 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1874 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 378 | 0.100 |
Why?
|
| Program Development | 1 | 2013 | 136 | 0.100 |
Why?
|
| Research Design | 1 | 2017 | 631 | 0.100 |
Why?
|
| Dermoid Cyst | 2 | 2002 | 15 | 0.090 |
Why?
|
| Adenoids | 1 | 2011 | 10 | 0.090 |
Why?
|
| Nose Neoplasms | 2 | 2002 | 36 | 0.090 |
Why?
|
| Androstadienes | 1 | 2011 | 74 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2013 | 9173 | 0.080 |
Why?
|
| Time Factors | 1 | 2020 | 5585 | 0.080 |
Why?
|
| Interleukins | 1 | 2011 | 134 | 0.080 |
Why?
|
| Audiology | 1 | 2009 | 2 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2017 | 2480 | 0.080 |
Why?
|
| Drainage | 2 | 2001 | 172 | 0.080 |
Why?
|
| Language Development Disorders | 1 | 2009 | 24 | 0.080 |
Why?
|
| Education | 1 | 2009 | 60 | 0.080 |
Why?
|
| Self Efficacy | 1 | 2009 | 61 | 0.080 |
Why?
|
| Retrospective Studies | 7 | 2013 | 10286 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2011 | 369 | 0.070 |
Why?
|
| Esophagoscopy | 1 | 2009 | 91 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 3927 | 0.070 |
Why?
|
| Data Collection | 1 | 2009 | 381 | 0.070 |
Why?
|
| Gastrostomy | 1 | 2008 | 69 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2011 | 4671 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 33 | 0.060 |
Why?
|
| Hypopharynx | 1 | 2006 | 9 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2006 | 50 | 0.060 |
Why?
|
| Respiratory System Abnormalities | 1 | 2006 | 5 | 0.060 |
Why?
|
| Abscess | 1 | 2006 | 95 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2006 | 138 | 0.060 |
Why?
|
| Sensation | 1 | 2006 | 52 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 491 | 0.060 |
Why?
|
| Placental Circulation | 1 | 2005 | 11 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2001 | 1619 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 287 | 0.050 |
Why?
|
| Observer Variation | 1 | 2004 | 626 | 0.050 |
Why?
|
| Middle Aged | 2 | 2017 | 28363 | 0.050 |
Why?
|
| United States | 1 | 2016 | 7767 | 0.050 |
Why?
|
| Neck | 2 | 2006 | 99 | 0.050 |
Why?
|
| Orbital Neoplasms | 1 | 2002 | 16 | 0.050 |
Why?
|
| Eyebrows | 1 | 2002 | 10 | 0.050 |
Why?
|
| Neurofibroma | 1 | 2002 | 12 | 0.050 |
Why?
|
| Facial Neoplasms | 1 | 2002 | 26 | 0.050 |
Why?
|
| Salivation | 1 | 2002 | 3 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2006 | 1010 | 0.050 |
Why?
|
| Hyperparathyroidism | 1 | 2001 | 65 | 0.050 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2001 | 10 | 0.040 |
Why?
|
| Injections | 1 | 2002 | 126 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2001 | 62 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2001 | 149 | 0.040 |
Why?
|
| Teratoma | 1 | 2001 | 58 | 0.040 |
Why?
|
| Encephalocele | 1 | 2001 | 25 | 0.040 |
Why?
|
| Twins | 1 | 2001 | 65 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2000 | 22 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2040 | 0.040 |
Why?
|
| Recurrence | 2 | 2001 | 1218 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2000 | 53 | 0.040 |
Why?
|
| Glycopyrrolate | 1 | 1999 | 4 | 0.040 |
Why?
|
| Suppuration | 1 | 1999 | 8 | 0.040 |
Why?
|
| Tonsillitis | 1 | 1999 | 5 | 0.040 |
Why?
|
| Anesthetics, Dissociative | 1 | 1999 | 5 | 0.040 |
Why?
|
| Cellulitis | 1 | 1999 | 19 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 1999 | 22 | 0.040 |
Why?
|
| Midazolam | 1 | 1999 | 49 | 0.040 |
Why?
|
| Sarcoma | 1 | 2001 | 225 | 0.040 |
Why?
|
| Ketamine | 1 | 1999 | 27 | 0.040 |
Why?
|
| Consciousness | 1 | 1999 | 32 | 0.040 |
Why?
|
| Otologic Surgical Procedures | 1 | 1999 | 13 | 0.040 |
Why?
|
| Tracheostomy | 1 | 1999 | 46 | 0.040 |
Why?
|
| Muscarinic Antagonists | 1 | 1999 | 61 | 0.040 |
Why?
|
| Patient Admission | 1 | 1999 | 122 | 0.040 |
Why?
|
| Safety | 1 | 1999 | 147 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 363 | 0.040 |
Why?
|
| Hospitalization | 1 | 2004 | 943 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 1999 | 142 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2883 | 0.040 |
Why?
|
| Endoscopy | 1 | 2002 | 374 | 0.040 |
Why?
|
| Respiration | 1 | 1999 | 281 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1973 | 0.030 |
Why?
|
| Granuloma | 1 | 1997 | 65 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 2001 | 443 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1999 | 307 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2000 | 514 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 1997 | 217 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 77 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2000 | 3651 | 0.030 |
Why?
|
| Tongue Neoplasms | 1 | 1996 | 51 | 0.030 |
Why?
|
| Tuberculosis | 1 | 1997 | 125 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 313 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 274 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 1996 | 180 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 277 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2011 | 14 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2011 | 140 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 173 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 349 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1999 | 2591 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1981 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1829 | 0.020 |
Why?
|
| Aged | 1 | 2004 | 20964 | 0.020 |
Why?
|
| Head | 1 | 2006 | 131 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 289 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 5960 | 0.010 |
Why?
|
| Image Cytometry | 1 | 2001 | 12 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 2001 | 75 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2001 | 64 | 0.010 |
Why?
|
| Parathyroidectomy | 1 | 2001 | 79 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 232 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 272 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2001 | 315 | 0.010 |
Why?
|
| Granulation Tissue | 1 | 1999 | 15 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2001 | 518 | 0.010 |
Why?
|
| Laryngostenosis | 1 | 1999 | 18 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 4033 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 1665 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 2642 | 0.010 |
Why?
|